EU to buy up to 300m doses of BioNTech-Pfizer’s Covid vaccine

EU to buy up to 300m doses of BioNTech-Pfizer’s Covid vaccine

Deal is largest order of breakthrough shot to date

The EU has agreed to buy up to 300m doses of the groundbreaking coronavirus vaccine developed by BioNTech and Pfizer, following widespread hopes that the jab will provide a route out of the pandemic.

Pfizer said deliveries were expected to begin by the end of the year, subject to the vaccine receiving regulatory approval from the European Medicines Agency.

“Today’s finalised supply agreement with the European Commission represents the largest initial order of vaccine doses for Pfizer and BioNTech to date and a major step toward our shared goal of making a Covid-19 vaccine available to vulnerable populations,” Albert Bourla, the chief executive of Pfizer, said in a statement on Wednesday.

The jabs will be made in Germany and Belgium, and member states that opted into the deal would place orders separately, the company said. Jens Spahn, Germany’s health minister, said on Tuesday that he was hoping to secure 100m doses of the vaccine for the country.